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Abstract
The adaptation of Chikungunya virus (CHIKV) to a new vector, the Aedes albopictus mosquito, is a major factor contributing
to its ongoing re-emergence in a series of large-scale epidemics of arthritic disease in many parts of the world since 2004.
Although the initial step of CHIKV adaptation to A. albopictus was determined to involve an A226V amino acid substitution
in the E1 envelope glycoprotein that first arose in 2005, little attention has been paid to subsequent CHIKV evolution after
this adaptive mutation was convergently selected in several geographic locations. To determine whether selection of
second-step adaptive mutations in CHIKV or other arthropod-borne viruses occurs in nature, we tested the effect of an
additional envelope glycoprotein amino acid change identified in Kerala, India in 2009. This substitution, E2-L210Q, caused a
significant increase in the ability of CHIKV to develop a disseminated infection in A. albopictus, but had no effect on CHIKV
fitness in the alternative mosquito vector, A. aegypti, or in vertebrate cell lines. Using infectious viruses or virus-like replicon
particles expressing the E2-210Q and E2-210L residues, we determined that E2-L210Q acts primarily at the level of infection
of A. albopictus midgut epithelial cells. In addition, we observed that the initial adaptive substitution, E1-A226V, had a
significantly stronger effect on CHIKV fitness in A. albopictus than E2-L210Q, thus explaining the observed time differences
required for selective sweeps of these mutations in nature. These results indicate that the continuous CHIKV circulation in
an A. albopictus-human cycle since 2005 has resulted in the selection of an additional, second-step mutation that may
facilitate even more efficient virus circulation and persistence in endemic areas, further increasing the risk of more severe
and expanded CHIK epidemics.
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Introduction
The potential of RNA viruses to emerge into new environments
often depends on their ability to efficiently adapt to new hosts.
These adaptations sometimes comprise a stepwise process that
includes 1) initial viral introduction/establishment in the recipient
species, followed by 2) finite adjustment/optimization of the virus
replication and transmission strategies for specific environments
associated with a new host [1,2]. This process has been well
documented for several single-host viruses such as pandemic
influenza A virus, the SARS coronavirus and canine parvovirus
(reviewed in [3,4]) that do not rely on alternating infection of
disparate hosts for their maintenance in nature. However, much
less is known about the adaptive processes that mediate cross-
species jumps for double-host viruses such as arthropod-borne
viruses (arboviruses). Several recent studies documented that the
acquisition of a single mutation in an arbovirus genome can
mediate their cross-species transfer [step (1)] [5–8]. However, in
none of these cases have subsequent, additional adaptive
mutations been detected, posing the question of whether selection
of second-step adaptive mutations is possible or necessary for these
viruses to persist in nature. This information is critical for
understanding and predicting the long-term consequences of
pathogen emergence and maintenance in affected areas, which in
turn could influence the development and success of targeted
intervention strategies for managing outbreaks.
A new lineage of Chikungunya virus (CHIKV) [arbovirus in
family Alphavirus, genus Togaviridae] emerged in 2004 in Kenya and
subsequently spread into many countries in the Indian Ocean
basin [hence the name: Indian Ocean lineage (IOL)], causing
devastating outbreaks of arthritic disease [9]. In India, IOL strains
were first detected in December 2005 followed by extensive
geographic expansion during 2006–2011 into 19 Indian states with
a total number of human cases estimated in 2007 at between 1.4
and 6.5 million [10,11]. During 2006, the states most affected by
CHIKV were Karnataka and Maharashtra, with a subsequent
shift to Kerala, Coastal Karnataka and West Bengal [12,13].
Several hypothetical factors may have contributed to the CHIKV
emergence/spread on the Indian subcontinent [14], including: 1)
the use of immunologically naı ¨ve human populations for
maintenance, amplification and virus dispersal among localities,
2) reliance on peridomestic and anthropophilic mosquitoes as
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adaptation to Aedes (A.) albopictus, which was previously considered
only a secondary CHIKV vector [9].
The mode of CHIKV maintenance in nature is complex and
appears to be region-specific. In Africa, CHIKV is maintained in
enzootic cycles involving transmission between non-human
primates and canopy-dwelling, primatophilic Aedes mosquitoes,
primarily A. furcifer, A. taylori, A. africanus, A. luteocephalus and A.
neoafricanus [15–19]. In contrast, CHIKV transmission in Asia is
believed to rely on humans alone as reservoir/amplification hosts,
with the domestic A. aegypti and to lesser extent the peridomestic A.
albopictus serving as primary urban mosquito vectors [19,20].
Recent evidence, however, suggests the possibility of additional
sylvatic, zoonotic transmission cycles [21,22].
In India, both urban CHIKV vectors are present, although
their distributions differ, and their epidemiologic significance for
CHIKV transmission probably varies locally. A. aegypti was
considered to be the most important during the early phase of
the CHIK epidemic in 2006 [23]. However, in subsequent years
(2007–2009), the involvement of A. albopictus as the principal vector
was documented at least in the states of Kerala and Coastal
Karnataka [24–27]. Interestingly, CHIKV transmission by A.
albopictus was shown to be associated with the acquisition of the
A226V amino acid substitution in the E1 envelope glycoprotein
[24,28–32] (Figure S1) that is responsible for alphavirus virion
assembly and virus fusion in endosomes of target cells [33–35].
The role of the E1-A226V substitution on CHIKV adaptation to
A. albopictus was directly demonstrated in laboratory studies,
including those using reverse genetics, showing that this mutation
is directly responsible for increased CHIKV infection, dissemina-
tion and transmission by this vector species [6,36]. In India,
evidence that CHIKV was undergoing genetic adaptation to A.
albopictus via the E1-A226V substitution first came from Kerala
State. During 2006, only the E1-226A variant was recovered
there; however, during subsequent years (2007–2008), all isolates
sequenced possessed the E1-226V residue [24] (Figure S1). In
2008 the E1-A226V substitution was also found among the
majority of CHIKV isolates from Coastal Karnataka, adjacent to
Kerala [37], suggesting introduction from the latter state.
In a follow-up study conducted in the state of Kerala, a novel
substitution in the E2 envelope glycoprotein, L210Q, was
discovered in all human and mosquito CHIKV isolates collected
during 2009 [27] (Figure S1). The E2 protein is located on the tips
of alphavirus spikes and interacts with host cell receptors as well as
with neutralizing antibodies [38,39]. The L210Q substitution has
not been reported in any other CHIKV strains, including those
isolated in Kerala State during 2006–2008. This suggests that E2-
L210Q substitution was selected as a result of CHIKV adaptation
to specific ecological conditions present in Kerala State. Position
E2-210 is located in the domain B of the E2 glycoprotein [39], and
several earlier studies demonstrated that mutations in this domain
mediate host specificity of several alphaviruses [5,7,40–42] as well
as the selection of escape mutants by neutralizing antibodies [43–
45]. Moreover, we recently demonstrated that epistatic interac-
tions between mutations at positions E1-226 and E2-211 of
CHIKV influence the penetrance of the E1-226V substitution for
fitness in A. albopictus [46]. The E2-I211T substitution was
probably acquired by IOL CHIKV strains around 2004–2005
[47], and provides a suitable background to allow CHIKV
adaptation to A. albopictus via the subsequent E1-A226V
substitution.
Considering that A. albopictus was a principal CHIKV vector in
the state of Kerala in 2009, it was hypothesized that the novel
substitution E2-L210Q provided an additional selective advantage
for CHIKV transmission by this mosquito [27]. To test this
hypothesis we undertook a comprehensive reverse genetic analysis
of the effects of E2-L210Q in various CHIKV hosts. Our
observations demonstrate that the E2-L210Q substitution medi-
ates a significant increase in CHIKV dissemination in A. albopictus
by increasing initial infectivity for midgut epithelial cells. In
addition, we show that the E1-A226V substitution has a
significantly stronger effect on CHIKV fitness in A. albopictus than
E2-L210Q, probably explaining the observed time differences
required for selective sweeps of these mutations in nature.
Results
The E2-L210Q substitution is responsible for increased
CHIKV dissemination in A. albopictus
To investigate the effect of the E2-L210Q substitution on
CHIKV fitness in A. albopictus mosquitoes, we employed a reverse
genetics approach based on the SL-CK1 strain of CHIKV
(hereafter abbreviated SL07), isolated in 2007 in Sri Lanka [9].
Previous phylogenetic studies indicated that SL07 evolved from
the Indian subgroup of IOL and represents one of the most closely
related isolates to strains responsible for CHIKV outbreaks in
India (including the Kerala state) [9,48]. The SL07 isolate was
passed only twice on Vero cells since its isolation from a febrile
patient, thus limiting the potential for cell culture-adaptive
mutations that can artificially influence alphavirus fitness in
vertebrate and/or mosquito hosts. The SL-07 strain has an alanine
residue at E1 position 226 and a leucine residue at E2-210,
corresponding to prototype IOL strain introduced into India in
late 2005. Since the E2-L210Q substitution was only detected in
CHIKV strains form Kerala that had previously acquired the A.
albopictus-adaptive E1-A226V substitution [24], single E1-A226V
and double (E1-A226V and E2-L210Q) substitutions were
introduced into an infectious clone (i.c.), generated from the
SL07 strain using site-directed mutagenesis. In addition, a clone
with the single E1-A226V substitution (SL07-226V) was geneti-
cally marked by introducing a synonymous mutation 6454ARC
that creates an ApaI restrictase site (SL07-226V-Apa). Previously
we demonstrated that the 6454ARC substitution does not
Author Summary
Since 2004, chikungunya virus (CHIKV) has caused a series
of devastating outbreaks in Asia, Africa and Europe that
resulted in up to 6.5 million cases of arthritic disease and
have been associated with several thousand human
deaths. Although the initial step of CHIKV adaptation to
A. albopictus mosquitoes, which promoted re-emergence
of the virus, was determined to involve an E1-A226V amino
acid substitution, little attention has been paid to
subsequent CHIKV evolution after this adaptive mutation
was convergently selected in several geographic locations.
Here we showed that novel substitution, E2-L210Q
identified in Kerala, India in 2009, caused a significant
increase in the ability of CHIKV to infect and develop a
disseminated infection in A. albopictus. This may facilitate
even more efficient virus circulation and persistence in
endemic areas, further increasing the risk of more severe
and expanded CHIK epidemics. Our findings represent
some of the first evidence supporting the hypothesis that
adaptation of CHIKV (and possible other arboviruses) to
new niches is a sequential multistep process that involves
selections of at least two adaptive mutations.
Chikungunya Virus Adapts via Sequential Mutations
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SL07-226V-Apa and SL07-226V-210Q were rescued by electro-
poration of in vitro-transcribed RNA into Vero cells. The specific
infectivity and viral titers in cell culture supernatants were almost
identical for all constructs (Table S1), indicating that the
introduced mutations did not attenuate CHIKV in Vero cells.
Although a variety of mechanisms may be involved, adaptation
of arboviruses for enhanced transmission by mosquitoes is typically
expected to result in an increased ability to develop a disseminated
infection leading to salivary gland infection. To investigate the
effect of the E2-L210Q substitution on CHIKV fitness in A.
albopictus mosquitoes, direct competition experiments were per-
formed using SL07-226V-Apa and SL07-226V-210Q viruses
(Figure 1). For these experiments, A. albopictus (Thailand strain)
was presented with blood meals containing a mix of 5x10
5 plaque
forming units (pfu)/mL of SL07-226V-Apa and 5x10
5 pfu/mL of
SL07-226V-210Q viruses (combined titer 10
6 pfu/mL) and 10
days post-infection (dpi), the presence of disseminated viral
infection as sampled from individual mosquito legs and heads
was analyzed as described in the Materials and Methods. The
dissemination of the SL07-226V-210Q in the Thailand colony of
A. albopictus was 4.3 times more efficient compared to SL07-226V-
Apa (Figure 1A)(p=0.021), supporting the hypothesis that
glutamine at E2-210 was selected in CHIKV population in
Kerala State due to its positive effect on CHIKV transmission. To
corroborate these findings, the ApaI site was introduced into the
backbone of SL07-226V-210Q, and the resultant virus (SL07-
226V-210Q-Apa) was tested in direct competition in A. albopictus
(Thailand colony) against SL07-226V that was produced by
reverting the ApaI site in SL07-226V-Apa to the wild-type (w.t.)
nucleotide sequence (Figure 1B). The dissemination of SL07-
226V-210Q-Apa was 3.4 times higher than that of SL07-226V
(p=0.017), indicating that the genetic marker was not responsible
for the competition outcome, and supporting the role of the E2-
L210Q substitution in increased CHIKV dissemination in A.
albopictus. To demonstrate that the outcome of competition
experiments was not affected by CHIKV propagation in Vero
cells (which were used to identify mosquitoes with disseminated
infection, prior to CHIKV genotype analysis), these cells were
infected at a multiplicity of infection of 0.1 pfu/cell in triplicate
with 1:1 mixtures of viruses that were used in mosquito
competition experiments. At 2 dpi, cell culture supernatants were
collected for viral RNA extraction and processed as described in
the Materials and Methods. No detectable differences in viral
fitness (changes in the ratios of the 2 viruses) were observed after
Vero cell passage, indicating that E2-L210Q substitution does not
affect CHIKV fitness in these cells (Figure S2).
Early studies of CHIKV competence to infect A. albopictus
demonstrated significant variation in susceptibility among different
geographic strains of this mosquito [49]. To demonstrate that the
effect of the E2-L210Q substitution on CHIKV dissemination in
A. albopictus was not limited to a particular geographic strain, we
also compared dissemination efficiency of the SL07-226V-Apa
versus SL07-226V-210Q viruses in mosquitoes derived from
Galveston, USA. Similar to the results with Thailand mosquitoes,
the E2-L210Q substitution provided a mean 4.5-fold increase in
dissemination efficiency of CHIKV (p=0.003) (Figure 1A). These
data suggest that the E2-L210Q substitution would likely have a
similar effect on CHIKV fitness in A. albopictus from Kerala State,
India, and from other parts of the world.
To investigate if the fitness advantage associated with the E2-
L210Q substitution is sufficient for selection of mutant viruses in a
w.t. CHIKV population, the SL07-226V-210Q was serially
passaged in the presence of a 100-fold excess of SL07-226V-Apa
(surrogate ‘‘wild-type’’ virus) in an alternating cycle between A.
albopictus mosquitoes and Vero cells. To initiate the cycle, A.
albopictus (Galveston colony) were presented with blood meals
containing 5x10
5 pfu/mL SL07-226V-Apa and 5610
3 pfu/mL
SL07-226V-210Q viruses (100-fold excess of SL07-226V-Apa).
After three consecutive passages, heads and legs of individual
mosquitoes were processed as described above to determine if
selection of virus with E2-L210Q substitution had occurred
(Figure 2A). Despite being present in 100-fold lower quantity in
the initial virus population, the SL07-226V-210Q virus alone was
detected in 31.6% of mosquitoes after 3 alternating mosquito-Vero
passages, whereas SL07-226V-Apa (w.t.) alone was found in
52.6% of mosquitoes, while 15.8% of mosquitoes had both
competitors in their heads and legs (Figure 2B) (p=0.227 one-
tailed McNemar test). These data indicate that the E2-L210Q
substitution has the potential to be selected in CHIKV populations
in locations where A. albopictus serves as the primary vector. The
31-fold increase over 3 artificial transmission cycles in the relative
frequency of SL07-226V-210Q over its initial ratio in blood meals
corresponds to a ca. 3-fold increase per cycle, which is in
agreement with fitness advantage of the E2-L210Q substitution
observed earlier in direct competition experiments (Figure 1).
The E2-L210Q substitution does not alter CHIKV fitness in
A. aegypti or human cells
Historically, A. aegypti mosquitoes were the primary vector of
CHIKV in Asia [19,20], and this species still plays a significant
role in CHIKV transmission in India [23,50–52]. To investigate if
the E2-L210Q substitution also affects CHIKV fitness in A. aegypti,
we analyzed the effect of E2-L210Q on CHIKV dissemination in
this vector using competition experiments as described above.
Since CHIKV transmission by A. aegypti has never been associated
with the E1-A226V substitution, we first used the w.t. genetic
background of the SL07 strain (E1-226A and E2-210L) to
introduce the E2-L210Q substitution. Also, because A. aegypti is
less susceptible to CHIKV than A. albopictus for strains with E1-
226V, we used higher total oral doses up to 2.4610
7 pfu/mL
(Figure 3A, 3B). The dissemination efficiency of SL07 and SL07-
210Q-Apa viruses in A. aegypti (Thailand strain) were almost
identical (p=0.395) (Figure 3A). Similarly, no difference in the
dissemination efficiency between SL07 and SL07-210Q-Apa
viruses was detected in Galveston A. aegypti mosquitoes (Figure
S3). Additionally, competition between SL07-226V-210Q-Apa
and SL07-226V viruses, which express E2-210Q and E2-210L
residues in the background of E1-226V, respectively, was also
analyzed in Thailand A. aegypti, again revealing no statistically
significant differences in dissemination efficiency [p=0.402]
(Figure 3B). These data indicate that it is unlikely that the
polymorphism at E2-210 affects CHIKV transmission by A. aegypti.
Alternatively, E2-L210Q could have been selected as a result of
CHIKV adaptation to a vertebrate host in India, probably
humans. Although we did not observe any fitness change
associated with this mutation during propagation of CHIKV in
Vero cells (derived from African green monkey kidneys), to extend
our analysis we repeated competition experiments using the
human-derived cell line 293 (embryonic human kidney) because
earlier studies showed that CHIKV can infect and replicate in
various primary human cell lines including epithelial, endothelial,
fibroblast, muscle satellite and macrophages (reviewed in [11]). No
detectable difference in fitness resulting from the E2-L210Q
substitution was observed in this cell culture model (Figure 3B,
3C). Although cell lines are not ideal surrogates for in vivo
infections, our data further support the conclusion that the E2-
L210Q substitution was most likely selected only by A. albopictus.
Chikungunya Virus Adapts via Sequential Mutations
PLoS Pathogens | www.plospathogens.org 3 December 2011 | Volume 7 | Issue 12 | e1002412Figure 1. Effect of the E2-L210Q substitution on dissemination of CHIKV in A. albopictus mosquitoes (Galveston and Thailand
colonies). Above each figure is a schematic representation of the viruses used in the competition assay. Asterisks indicate authentic (w.t.) residues
for the SL07 strain at the indicated positions. A 1:1 mixture of viruses [SL07-226V-Apa and SL07-226V-210Q] (A) and [SL07-226V and SL07-226V-210Q-
Apa] (B) was orally presented to A. albopictus and at 10 dpi, the presence of disseminated E2-210L and E2-210Q CHIKV infection was assayed as
described in the Materials and Methods. Graphs show numbers and proportions of mosquitoes containing virus populations expressing leucine
(210L), glutamine (210Q) or containing both residues (210L/210Q) in mosquitoes heads and legs (representing disseminated infections). The
difference in number of mosquitoes with E2-210L versus E2-210Q residues was tested for significance with a one-tailed McNemar test. BM indicates
combined titers of competitors in blood meals used for mosquito infection.
doi:10.1371/journal.ppat.1002412.g001
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infectivity for midgut cells of A. albopictus
Previous studies determined that the A. albopictus-adaptive E1-
A226V substitution acts primarily at the level of midgut infectivity.
It was suggested that efficient CHIKV infection of and replication
in midgut cells promotes more active CHIKV dissemination and
transmission by this vector [6,36,46], thus allowing the selection of
A. albopictus-adapted CHIKV strains in nature. To explore which
step during CHIKV infection of A. albopictus mosquitoes is affected
by the E2-L210Q mutation, we first compared the relative ratios
of SL07-226V-Apa and SL07-226V-210Q RNAs in whole
mosquitoes, mosquito midguts and mosquito carcasses (bodies
without midguts) after oral infection (Figure 4A). We observed a
marked increase in the relative amount of E2-210Q RNA in all
samples analyzed, including midguts at 7 dpi. Furthermore,
similar increases in the relative amount of E2-210Q RNA in
mosquito midguts were observed as early as day 1 post infection,
regardless of which of the two competitors was marked by the ApaI
site (Figure 4B, 4C). In contrast, no difference in the relative
amounts of E2-210Q versus E2-210L RNAs were observed 2 days
after intrathoracic infection of A. albopictus, when CHIKV titers
peak (Figure 4D). When injected intrathoracically, CHIKV does
not require infection of and replication within mosquito midguts to
disseminate to other organs and tissues, suggesting that the initial
infection/replication of the midgut epithelium is a major site of
selection of the E2-L210Q substitution in A. albopictus.
To further test the hypothesis that the E2-L210Q substitution
affects CHIKV fitness only during initial infection of the A.
albopictus midgut, we first compared infection rates of mosquitoes
presented orally with serial dilutions of the viruses expressing
either E2-210L or E2-210Q residues in the backbone of the SL07
strain that has the E1-A226V substitution. The E2-210Q residue
was associated with significantly higher infectivity (p=0.006 and
p=0.034, Fisher `s exact test) for A. albopictus (Thailand) at the
blood meal titers of 3.5 and 2.5 Log10(pfu)/mL, and the oral
infectious dose 50% (OID50) value calculated for SL07-226V-
210Q was 8.9 times lower (higher infectivity) than that for SL07-
226V (Figure 5A, 5B). The lack of a significant difference in
infection rates after the highest dose (4.54 Log10(pfu)/mL)
probably reflected the oral dose nearing saturation. By way of
comparison, earlier studies, including those using the SL07 strain,
determined that the well-established A. albopictus-adaptive substi-
tution E1-A226V mediates a much greater, ,100-fold decrease in
OID50 values [6,9].
To directly study the effect of E2-L210Q substitution on initial
CHIKV infection of A. albopictus midgut cells, we developed a
replicon/helper system for the SL07 strain. Sub-genomic replicons
of alphaviruses can be packaged into virus-like particles (VLPs) by
co-transfection of replicon and helper RNAs into susceptible cells
[53]. The helper RNA provides the structural genes that package
replicon RNA into VLPs, but the helper RNA itself is not
packaged into the VLPs. Therefore, the VLPs are capable of
primary infection and replicon RNA replication within cells, but
cannot spread to neighboring cells due to the lack of the structural
genes in the replicon. Thus, replicon VLPs allowed us to
investigate the effect of mutations of interest on initial infection
of midgut cells.
Since transfection efficiency of viral RNA is critical in
determining the efficiency of VLP production, we switched to
BHK-21 cells that have superior RNA susceptibility compared to
Vero cells. Earlier, we observed that CHIKV isolates that have not
been passaged in rodent-derived cells lines (including SL07) are
impaired in their ability to replicate in BHK-21 cells (KT, SCW,
unpublished). Therefore, to ensure efficient recovery of CHIKV
VLPs from BHK-21 cells, double BHK-adaptive substitutions
(nsP1-L407P and nsP3-T348A) were introduced into the SL07 i.c.
(see Materials and Methods for details). Although these substitu-
tions increase replication capacity, rather than electroporation
efficiency, of CHIKV in BHK-21 cells, they have no effect on
mosquito infection (data not shown). The modified SL07 i.c
(contains nsP1-L407P and nsP3-T348A substitutions) was subse-
quently used to generate all CHIKV replicons used in the
mosquito infectivity study.
The SL07 replicon expressing green fluorescent protein (GFP)
was packaged into VLPs using w.t. SL07 helper (with E2-210L
and E1-226A residues) or using a modified helper encoding E2-
L210Q and E1-A226V substitutions. The SL07 replicon express-
ing cherry fluorescent protein (CFP) was packaged into VLPs using
a helper encoding E2-210L and E1-226V residues (Figure 6A). In
addition, the ApaI marker was introduced into the GFP-expressing
replicon. The infectious titers of all recovered VLPs, as determined
by titration on Vero cells, were identical (Figure 6A). Infection of
Vero and C6/36 cells with 1:1 mixtures of GFP and CFP
expressing VLPs [based on infectious unit (i.u.) titers] yielded equal
number of cells expressing these fluorescent proteins (data not
shown).
For mosquito experiments, GFP- and CFP-expressing VLPs
were mixed 1:1 (based on i.u. titers) and presented in blood meals
to A. albopictus as shown in (Figure 6A). At 1 and 2 dpi, midguts of
individual mosquitoes were dissected and analyzed by fluorescent
microscopy to determine a number of cells expressing GFP and
CFP in the same fields of vision (Figure 6B). We found that, on
average, midgut cells were 4–5 times more likely to become
infected with VLPs expressing the E2-210Q residue as compared
with VLPs expressing E2-210L (Figure 6D, 6E). Similarly, 4–5 fold
increases in relative amounts of E2-210Q RNA were observed
Figure 2. Effect of the E2-L210Q substitution on positive
s e l e c t i o no fam u t a n tC H I K Vs t r a i nw i t h i naw i l d - t y p e
population during alternating passaging in A. albopictus
mosquitoes and Vero cells. A. Schematic representation of the
alternating passage experiment. The SL07-226V-210Q virus was mixed
with 100-fold excess of SL07-226V-Apa virus and presented orally to A.
albopictus (Galveston). At 10 dpi CHIKV was extracted from combined
head and leg homogenates derived from 50 individual mosquitoes and
used for Vero cells infection. The cycle was repeated a total of 3 times.
At 10 dpi of third mosquito passage, heads and legs of individual
mosquitoes were processed as described in the Materials and Methods.
B. Graph shows numbers and proportions of mosquitoes containing
virus populations expressing leucine (210L), glutamine (210Q) or both
residues (210L/210Q) in mosquito heads and legs after the third
passage in A. albopictus (representing disseminated infections). The
original mixture used to initiate the infections was not quantified
because the PCR-restriction digest assay cannot detect a minority
population present at only 1% frequency.
doi:10.1371/journal.ppat.1002412.g002
Chikungunya Virus Adapts via Sequential Mutations
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infected midguts (Figure S4). Infectious viruses were not recovered
after infecting Vero cells with homogenates of 30 mosquitoes
infected with VLPs mixes (see Materials and Methods for details),
indicating that the hypothetical formation of full-length viruses via
recombination between helper and replicon RNAs, which could
confound the interpretation of this experiment, did not occur.
Altogether, these data demonstrate that the E2-L210Q substitu-
tion acts specifically by increasing initial CHIKV infectivity for
midgut cells of A. albopictus.
In a parallel experiment using VLPs, we also compared the
effect of the previously characterized E1-A226V substitution on
CHIKV infectivity for midguts of A. albopictus (Figure 6A). The
CFP-expressing replicon packaged using a helper encoding E2-
210L and E1-226V residues (CFP/E2-210L/E1-226V) was
competed against GFP-expressing replicon packaged using w.t.
SL07 helper encoding E2-210L and E1-226A residues (GFP/E2-
210L/E1-226A). In contrast to the polymorphism at E2-210, the
valine residue at position E1-226 provided a far greater (41-43
fold) increase in a midgut cell infection compared to the alanine
Figure 3. The effect of the E2-L210Q substitution on CHIKV fitness in A. aegypti mosquitoes and 293 cells. Above each figure is a
schematic representation of the viruses used in the competition assay. Asterisks indicate authentic (w.t.) residues for the SL07 strain at the indicated
positions. A and B. The effect of the E2-L210Q substitution on CHIKV fitness in A. aegypti. Graphs show numbers and proportions of mosquitoes
containing virus populations expressing leucine (210L), glutamine (210Q) or both residues (210L/210Q) in the background of E1-226A (A) and E1-
226V (B) viruses in heads and legs of A. aegypti (Thailand colony) assayed at 10 dpi. BM indicates combined titers of CHIKV (E2-210L and E2-210Q) in
blood meals used for mosquito infection. C and D. The effect of the E2-L210Q substitution on CHIKV fitness in 293 cells. 293 cells were infected at
multiplicity of 0.1 pfu/cell in triplicate with 1:1 mixture of [SL07-226V-Apa and SL07-226V-210Q] (C) and [SL07-226V and SL07-226V-210Q-Apa] (D). At
2 dpi, supernatants were collected for RNA extraction and RT-PCR analysis. The relative fitness (RF) within a given competition was determined as the
average ratio between E2-210L and E2-210Q bands in the sample (r), divided by the starting ratio of E2-210L and E2-210Q bands in the inoculum (i)
used for infection.
doi:10.1371/journal.ppat.1002412.g003
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with previous results using infectious viruses [6,36]. These data
also indicate that the results of experiments using VLPs with 2
different fluorescent reporter proteins (GFP and CFP) cloned into
replicons RNAs are not influenced by those reporter proteins
themselves. The significant difference of ,10-fold between the
effects of the polymorphisms at positions E1-226 versus E2-210 on
CHIKV infectivity (p=0.026 and p=0.005 for 1 and 2 dpi
respectively) (Figure 6D, 6C) indicates that the E1-A226V
substitution exerts significantly stronger selection compared to
E2-L210Q, and thus would be expected to be selected faster
during CHIKV transmission by A. albopictus.
To corroborate these findings we also analyzed effect of the E2-
L210Q substitution on CHIKV infectivity for midgut cells of A.
albopictus when this substitution is expressed in the background of
w.t.CHIKVwith the E1-226A residue.Forthis experiment,a GFP-
expressing repliconwaspackaged usinga w.t.SL07 helperencoding
E2-210L and E1-226A residues(GFP/E2-210L/E1-226A), and was
competed against a CFP-expressing replicon packaged using a
helper encoding E2-210Q and E1-226A residues (GFP/E2-210Q/
E1-226A). The E2-L210Q substitution caused a 2.3–2.4-fold
increase in CHIKV infectivity for A. albopictus midgut cells
(Figure 7), which was about 17.5 times weaker than the effect of
the E1-A226V substitution in the same genetic background.
Similarly, using direct competition experiments between infectious
viruses SL07 and SL07-210Q-Apa (both have the E1-226A residue)
we observed that the E2-L210Q substitution provided a mean 2.0-
fold increase in dissemination efficiency of CHIKV (p=0.022)
(Figure S5)inthe ThailandstrainofA. albopictus.These data indicate
thattheE2-L210Qsubstitutionwouldbeselected moreefficientlyin
CHIKV strains that previously acquired the E1-226V mutation.
Discussion
In this study we showed that an E2-L210Q substitution recently
identified in CHIKV populations of Kerala State, India, when
Figure 4. Effect of the E2-L210Q substitution on CHIKV fitness in A. albopictus bodies, carcasses and midguts after oral or
intrathoracic infection. A, B and C. A. albopictus were fed blood meals containing 1:1 mixes of [SL07-226V-Apa and SL07-226V-210Q] (A and B)
and [SL07-226V and SL07-226V-210Q-Apa] (C) viruses. At 1, 2, 3 (B and C) and 7 dpi (A) whole mosquito bodies (A), carcasses without midguts (A), or
midguts (A, B and C) were collected in pools of ten and processed as described above. BM indicates combined titers of competitors in blood meals
used for mosquito infection. D. SL07-226V-Apa and SL07-226V-210Q were mixed at a 1:1 ratio (total concentration of 5610
4 pfu/mL), and 0.5 mL was
used to infect A. albopictus intrathoracically. At 1 and 2 dpi whole mosquitoes were collected in pools of 5 and processed as described above. The
relative fitness (RF) for viruses during competition was determined as the average ratio between E2-210Q and E2-210L bands in the sample, divided
by the starting ratio of E2-210Q and E2-210L bands in the BM (A, B and C) or inoculum (D) used for mosquito infections.
doi:10.1371/journal.ppat.1002412.g004
Figure 5. Effect of the E2-L210Q substitution on CHIKV infectivity for A. albopictus. Mosquitoes (Thailand) were orally infected with serial
10-fold dilutions of SL07-226V or SL07-226V-210Q viruses in infectious blood meals (BM). At 10 dpi CHIKV infection in individual mosquito was
detected by observing virus-induced CPE in Vero cells inoculated with mosquito homogenates. The OID50 values were calculated using the PriProbit
program (version 1.63) and expressed as Log10(pfu)/mL (A). The difference in the infection rates between SL07-226V and SL07-226V-210Q viruses was
tested for significance with a two-tailed Fisher `s exact test (B).
doi:10.1371/journal.ppat.1002412.g005
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PLoS Pathogens | www.plospathogens.org 7 December 2011 | Volume 7 | Issue 12 | e1002412Figure 6. Effect of the E2-L210Q and E1-A226V substitutions on infectivity of CHIKV VLPs for midguts of A. albopictus (Thailand). A.
Schematic representation of VLP production and the experimental design used. At 1 and 2 dpi, mosquito midguts were analyzed by fluorescent
microscopy to determine the number of cells expressing GFP and CFP in the same field of vision. B. Representative image showing number of GFP-
and CFP-expressing cells in individual midguts infected with GFP/210Q/226V and CFP/210L/226V VLPs at 1 and 2 dpi. C. Representative image
showing number of GFP- and CFP-expressing cells in individual midguts infected with CFP/210L/226V and GFP/210L/226A VLPs at 1 and 2 dpi. D and
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substitution, confers a selective advantage by increasing initial
infection of A. albopictus midgut epithelial cells. Efficient infection of
midguts promotes subsequent CHIKV dissemination into the
hemocoel and transmission by this vector. However, the E2-
L210Q substitution has no apparent effect on CHIKV fitness in
the other primary mosquito vector, A. aegypti, or on fitness in cell
culture models for primate infection (Vero and 293 cells). These
results as well as surveillance data indicating that CHIKV was
transmitted primarily by A. albopictus in Kerala state of India when
the E2-L210Q substitution was first detected [24–27], provide a
comprehensive evolutionary explanation for its appearance in
2009. These results also indicate that adaptation of CHIKV to A.
albopictus mosquitoes mediated by the previously characterized E1-
A226V substitution was probably just a beginning of multi-step
adaptive process that included the selection of a second (E2-
L210Q) and possibly additional, future mutational steps by IOL
strains now circulating in urban areas. These mutations, which
have no deleterious effect on transmission by A. aegypti, will enable
CHIKV to even more efficiently exploit urban transmission in
environments populated by A. albopictus, but also to maintain the
ability to utilize A. aegypti, which tends to occur in major urban
centers [54]. Thus, our findings regarding the continued
adaptation of CHIKV to A. albopictus raise serious public health
concerns that even more efficient transmission may exacerbate the
already devastating CHIK epidemics in India and Southeast Asia.
Furthermore, the introduction of the E2-L210Q strain into new
areas like Italy and France, where autochthonous cases have
already occurred [55–57], could spread epidemics into temperate
climates where A. albopictus thrives. Considering the broad global
distribution of A. albopictus, including nearly throughout the
Americas, the E2-L210Q substitution may significantly increase
the risk of CHIKV becoming endemic in additional locations.
Interestingly, Niyas et al. (2010) demonstrated that CHIKV
strains with the E2-L210Q substitution can be isolated from adult
A. albopictus mosquitoes that were reared from wild-caught larvae
collected in Kerala State, suggesting that transovarial transmission
(TOT) may also play a role in CHIKV maintenance, especially
during dry seasons [27,58]. Also, evidence suggests that TOT
occurred in a small percentage of wild mosquitoes during recent
CHIK outbreaks on Reunion Island, Madagascar, and in
Thailand [59–61]. Although we did not attempt to study the
effect of the E2-L210Q substitution on TOT, and at least one
laboratory study failed to demonstrate TOT in A. albopictus of
CHIKV strains with the E1-A226V substitution [58], so the
possibility that CHIKV mutations could influence rates of TOT
warrants a thorough investigation.
The molecular mechanism explaining the effects of the E2-
L210Q substitution on CHIKV infectivity for A. albopictus midgut
cells remains unknown. Earlier, we hypothesized that the E2
region around position 211 could be directly involved in
interactions with a specific cell surface receptor [46]. We showed
that the E2-211T residue mediates a significant increase in
infectivity for A. albopictus in concert with the E1-A226V
substitution, and that residue E2-211I, which is common among
CHIKV strains, blocks this effect. Moreover, using virus overlay
protein binding assays (VOPBA) to study CHIKV binding to the
proteins associated with the brush border membrane fraction of A.
albopictus midguts, we demonstrated that the E2-T211I substitution
dramatically alters CHIKV interactions with as yet unidentified
proteins (KT unpublished). The recently determined crystal
structure of the CHIKV E2 glycoprotein [39] provides additional
insights into the possible involvement of residues E2-211 and E2-
210 in interactions with a putative mosquito receptor (Figure 8).
Both positions are located at the C’B sheet of the E2 protein, which
is exposed on the virion surface on the lateral side of domain B,
suggesting that these positions could be involved in interactions
with cellular proteins. Substitutions of the aliphatic moieties with
polar residues in this region may therefore be directly responsible
for changing CHIKV affinities to as yet unidentified receptor(s).
Interestingly, positions E2-207, E2-213 and E2-218, which have
been shown to be involved in VEEV adaptation to equine and
mosquito hosts [5,7,42], are also located in the same lateral surface
of domain B, further supporting the hypothesis that E2-L210Q
enables CHIKV to interact with a particular protein expressed on
the surface of midgut cells. The studies to identify these protein(s)
are underway.
In the study by Niyas et al (2010) that discovered the E2-L210Q
substitution in CHIKV strains from Kerala, only limited portions
of CHIKV genomes including the nsP2, E2 and E1 genes were
sequenced [27]. Since we did not have an access to these isolates
or to complete sequence of these strains, we cannot rule out the
possibility that other genome regions could be influencing CHIKV
evolution in Kerala State. Epistatic mutations in different genome
positions can dramatically affect CHIKV infection of A. albopictus
[9]. For example, the recently determined, lineage-specific
epistatic interactions between positions E1-226 and E1-98
probably limited for at least 60 years the emergence and
establishment of new CHIKV strains in Asian regions inhabited
by A. albopictus [9]. This suggests that Kerala strains of CHIKV
might have acquired adaptive substitutions in addition to E2-
L210Q that promote efficient transmission in the human-A.
albopictus cycle, and indicates the need for a more detailed,
continuous molecular characterization of CHIKV strains from
throughout its distribution.
We also investigated if residue E1-226 has an epistatic effect on
amino acid E2-210. The E2-L210Q substitution was detected only
in CHIKV strains that already acquired the E1-A226V substitu-
tion. We observed that the E2-L210Q substitution mediates a 4–5-
fold increase in A. albopictus midgut infectivity when expressed in
the background of E1-226V, whereas the same substitution caused
only a 2.3–2.4-fold increase when expressed in the background of
E1-226A (Figure 6 and 7). These results indicate that selection of
this mutation would have been even less efficient if it had occurred
in a CHIKV strain that did not yet acquire E1-A226V change.
Interestingly, our data show that, with regard to CHIKV
infectivity of A. albopictus midgut cells, E2-L210Q has an
approximately 17-fold (E1-226A background) or 10-fold (E1-
226V background) weaker effect compared with E1-A226V
(Figure 6 and 7). This could explain why E1-A226V was selected
convergently by unrelated CHIKV strains on at least 4 well
documented occasions, while selection of E2-L210Q has thus far
been observed only once in Kerala State (Figure S1). The stronger
fitness effect of E1-A226V is consistent with its historically faster
selection, which resulted in a selective sweep in parts of the Indian
Ocean, India and Southeast Asia, compared with E2-L210Q,
which has predominance in only one location. After CHIKV
introduction into a region with large A. albopictus populations, the
E. Each dot corresponds to a fold-difference in the number of cells expressing GFP vs. CFP [E2-210 (Q/L)] or CFP vs. GFP [E1-226 (V/A)] in individual
mosquito midguts at 1 dpi (D) and 2 dpi (E). Red horizontal line represents the mean fold-difference for 5–10 individual midguts. The difference
between strains expressing E2-L210Q and E1-A226V residues on VLP infectivity was compared for significance with a two-tailed Student `s t-test.
doi:10.1371/journal.ppat.1002412.g006
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PLoS Pathogens | www.plospathogens.org 9 December 2011 | Volume 7 | Issue 12 | e1002412Figure 7. Effect of the E2-L210Q substitution, expressed in the background of E1-226A, on infectivity of CHIKV VLPs for midguts of
A. albopictus (Thailand). A. Schematic representation of VLP production and the experimental design. At 1 and 2 dpi, mosquito midguts were
analyzed by fluorescent microscopy to determine the number of cells expressing GFP and CFP in the same field of vision. B. Representative image
showing number of GFP- and CFP-expressing cells in individual midguts infected with GFP/210L/226V and CFP/210Q/226A VLPs. C. Each dot
corresponds to the fold-difference in the number of cells expressing CFP vs. GFP [E2-210 (Q/L)] in individual mosquito midguts at 1 dpi and 2 dpi. Red
horizontal line represents the mean fold-difference for 10 individual midguts.
doi:10.1371/journal.ppat.1002412.g007
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appear [24,28], whereas the E2-L210Q change was observed after
at least 3 years of circulation in Kerala State [27] (Figure S1).
More studies are needed to determine the precise dynamics of the
selective sweeps associated with both mutations.
Another interesting observation is that both A. albopictus-
adaptive substitutions exert their effect on CHIKV fitness
primarily at the level of midgut infectivity (Figure 4 and 6). The
overall increase in the number of midgut cells infected with
CHIKV VLPs expressing E2-210Q correlates with the increase in
dissemination efficiency observed for infectious viruses. Also, the
relative increase in the amount of E2-210Q RNA in midguts
infected with VLPs is almost indistinguishable from the relative
increase in amount of E2-210Q RNA in midguts exposed to
infectious viruses (Figure 4 and S4). Although we did not examine
replication in a comprehensive set of mosquito tissues, these results
suggest that, after establishing an initial infection from the midgut
lumen, the subsequent spread of viruses among neighboring cells is
not influenced by position E2-210. Moreover, no differences were
observed in CHIKV replication in A. albopictus bodies after
intrathoracic infection, indicating that replication of CHIKV in
secondary mosquito organs also is unaffected by residue E2-210
(Figure 4). Similar observations were provided earlier for position
E1-226 [62]. Experimental studies of epizootic versus enzootic
VEEV VLP interactions with the epidemic vector, A. taeniorhynchus,
also indicated that midgut epithelia is the target organ for VEEV
adaptation to this vector [63]. These findings suggest that
adaptation of alphaviruses to a mosquito vector primarily occurs
at the level of midgut infection.
In summary, we demonstrated that adaptation of CHIKV to a
new mosquito vector can be a multistep process that, since 2005,
has involved at least 2 amino acid substitutions in the envelope
glycoproteins. The substitution that provides the strongest selective
advantage, E1-A226V, was followed by second adaptive mutation
(E2-L210Q) that has resulted in a strain circulating in India with
the fittest phenotype detected yet for transmission by A. albopictus.
We hypothesize that this sequential adaptation will facilitate even
more efficient circulation and persistence of the A. albopictus-
adapted strains in endemic areas and will further increase the risk
of expanded and more severe CHIK epidemics in new geographic
ranges. This underscores the need for continued surveillance and
studies of ongoing CHIKV evolution, as well as the molecular




The SL07 (SL-CK1) strain of CHIKV was isolated in 2007
from a human in Sri-Lanka (GenBank Acc. No. HM045801.1).
This strain belongs to Indian subgroup of the IOL [9] and was
obtained from the World Reference Center for Emerging Viruses
and Arboviruses (WRCEVA) at the University of Texas Medical
Branch, Galveston, TX after its generous submission by Aravinda
de Silva of the University of North Carolina. Since its isolation the
strain was passed twice on Vero cells before being used for i.c.
construction. Viral RNA was extracted from lyophilized virus
stock using TRIzol reagent (Invitrogen, Carlsbad, CA), reverse-
transcribed using Superscript III (Invitrogen, Carlsbad, CA) and
cDNA was amplified using Pfu DNA polymerase (Stratagene, La
Jolla, CA) and PCR. To assemble the i.c., overlapping RT-PCR
amplicons were cloned into modified pSinRep5 vector (Invitrogen)
under the control of an SP6 promoter using a strategy described
previously for strain LR2006 OPY1 [64]. Point mutations
10670CRT (E1-A226V), 9170TRA (E2-L210Q) and
6454ARC (synonymous, ApaI marker) were introduced in various
combinations into the i.c. of SL07 using conventional PCR-based
cloning methods [65], and the PCR-generated regions were
completely sequenced. Plasmids encoding sub-genomic replicons
of strain SL07 were generated from the i.c. of the BHK-21 cell-
adapted version of this strain [SL07-BHK that contains
1296TRC and 5087ARG (nsP1-L407P and nsP3-T348A)
substitutions] which was reported previously [9]. These mutations
were identified by electroporation of the SL07 i.c. into BHK-21
cells, followed by sequencing of the recovered, plaque purified
viruses. Replicons were generated by replacing the structural gene
region of SL07-BHK with the sequence of eGFP or CFP genes
utilizing standard techniques [64,66]. In addition, a point
mutation 6454ARC (synonymous, ApaI marker) was introduced
into the pRep-GFP construct that allows comparison of the
relative RNA quantities in an experimental, mixed infection
sample. The helper plasmids were generated by deleting the 373–
7270 nt. cDNA fragment from i.c. of SL07 that has mutations of
interest at E1-226 and E2-210. Plasmids were propagated using
the MC1061 strain of E. coli in 2xYT medium and purified by
centrifugation in cesium chloride gradients. Detailed information
for all plasmids is available from the authors upon request.
Cells and mosquitoes
Vero cells (African green monkey kidney) were propagated at
37uC, with 5% CO2, in Minimal Essential Medium (MEM;
Invitrogen, Carlsbad, CA) supplemented with 5% fetal bovine
serum (FBS). BHK-21(S) [Baby Hamsters Kidney] and 293
(Human Embryonic Kidney) cells were maintained at 37uC with
5% CO2 in MEM-alpha (Invitrogen) supplemented with 10% FBS
and 1x MEM vitamin solution (Invitrogen). The Galveston
colonies of A. albopictus and A. aegypti mosquitoes were established
from the mosquitoes collected in Galveston, TX (USA). Thailand
colonies of A. albopictus and A. aegypti mosquitoes were established
from mosquito eggs collected in Bangkok, Thailand. All
manipulations and handling of mosquitoes were done as described
previously [67].
Recovery of the infectious viruses and VLPs from the i.c.
Infectious viruses were generated by electroporation of the in-
vitro transcribed RNA into Vero cells. RNA was transcribed from
Figure 8. Atomic structure of the CHIKV E2 glycoprotein
demonstrating positions in domain B involved in regulation
of the alphavirus host range. A. Trimeric form of E2 protein, view
from the top. B. Domain B of CHIKV E2 protein with positions involved
in CHIKV adaptation to A. albopictus [green (E2-210) and cyan (E2-211)].
Positions involved in modulation of VEEV host range are in magenta
[5,7,42]. Image is constructed based on atomic structure of CHIKV E2
protein [PDB ID:3N44, [39]]. The 3-D model was analyzed using the
PyMol molecular viewer [70].
doi:10.1371/journal.ppat.1002412.g008
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mMESSAGE mMACHINE kit (Ambion, Austin TX). Ten mgo f
RNA were electroporated into 10
7 Vero cells using a BTX-
Harvard Apparatus ECM 830 Square Wave Electroporator
(Harvard Apparatus, Holliston, MS) and 2mm cuvette at the
following conditions: 680V, pulse length 99 ms, 5 pulses, with an
interval between the pulses of 200ms. Cells were transferred to a
75 cm
2 tissue culture flasks with 14 mL of Leibovitz L-15 (L-15)
medium supplemented with 10% FBS and 5% tryptose phosphate
broth (Sigma-Aldrich, St. Louis, MO). At 3 h post electroporation
the cell supernatant was replaced with 14 mL of L-15 medium and
maintained at 37 uC without CO2. Cell culture supernatants were
collected at 24 and 48 h and stored at 280uC.
To estimate the specific infectivity of electroporated RNAs, an
aliquot containing 1x10
5 electroporated Vero cells was serially ten-
fold diluted and cells were allowed to attach to sub-confluent
monolayers (1x10
6 cells/well) of uninfected Vero cells in six-well
plates [64]. After 2 h of incubation at 37uC, cells were overlaid
with 0.5% agarose in MEM supplemented with 3.3% FBS and
incubated for 48 h until plaques developed. The results (specific
infectivity values) were expressed as pfu/mg of electroporated RNA
(Table S1). Titers of the viruses recovered after electroporation
and all experimental samples were determined by titration on
Vero cells by plaque assay as previously described [7].
To generate CHIKV VLPs expressing residues of interest in E2
and E1 glycoproteins, BHK-21(S) cells were used, which have
superior RNA susceptibility compared to Vero cells. To ensure
efficient recovery of CHIKV VLPs from BHK-21 cells, all
CHIKV replicons were designed to include BHK-adaptive
mutations (nsP1-L407P and nsP3-T348A) identified after rescue
of w.t. i.c’s in BHK-21(S) cells. Ten micrograms of in-vitro
transcribed replicon and helper RNA were mixed and electropo-
rated into 10
7 BHK-21(S) cells as described above for Vero cells.
Cells were maintained in L-15 medium at 37uC, followed by
harvesting supernatants at 30 h post-electroporation. The titer of
VLPs was determined by titration on Vero cells as described
earlier [68]. Briefly, 1610
6 Vero cells were seeded in six-well
plates and, after a 16 h incubation at 37uC, monolayers were
infected with 10-fold dilutions of the samples for 1 h at 37uC,
followed by adding 2 mL of MEM. After 24 h of incubation at
37uC the numbers of GFP- or CFP-expressing cells were
quantified by fluorescent microscopy and titers were expressed
as infectious units (i.u.)/mL.
Mosquito infectivity experiments
The role of viral mutations at position E2-210 on CHIKV
dissemination in A. albopictus and A. aegypti mosquitoes was
analyzed using direct competition experiment as described earlier
[6,9]. A pair of viruses that differed by mutations of interest in the
E2 protein was mixed at a 1:1 ratio, with one of the viruses
containing the ApaI marker. Viral mixes were used to prepare
infectious blood meals by dilution in an equal volume of the
defibrinated sheep blood (Colorado Serum, Denver, CO), then
orally presented to 4–5 day old female mosquitoes at 37uCa s
described previously [6,67]. Ten days post infection, heads and
legs of individual mosquitoes were triturated in 500 mL of MEM
media containing 5 mg/mL of Amphotericin B (Fungizone), and
100 mL of clarified supernatant were added to duplicate wells of a
96-well plate containing 5x10
4 Vero cells/well. At 3 dpi,
supernatant from virus-induced CPE (cytopathic effect)-positive
wells was used for RNA extraction followed by RT-PCR with
41855ns-F5 (5 `-ATATCTAGACATGGTGGAC) and 41855ns-
R1 (5 `-TATCAAAGGAGGCTATGTC) primers sets using One-
Step RT-PCR kit (Qiagen, Valencia, CA). The PCR products
were digested with ApaI restrictase (NEB, Ipswich, MA) and
separated on 1.5% agarose gels followed by ethidium bromide
staining. One PCR band in the digested sample corresponded to
disseminated infection for one out of two viruses in the pair; two
bands indicated that both viruses disseminated in the same
mosquito. Differences in dissemination efficiencies were tested for
significance with a one-tailed McNemar test.
Viral competition experiments with serial, alternating CHIKV
passaging in A. albopictus and Vero cells were performed as
described above with minor modifications. For the first passage,
virus SL07-226V-210Q was mixed with 100-fold excess SL07-
226V-Apa to generate infectious blood meals containing
5x10
5 pfu/mL (combined). The blood meal was used for oral
infection of A. albopictus (Galveston colony) followed by virus
extraction from combined head and leg homogenates derived
from 50 individual mosquitoes in 1.5 mL of MEM medium at
10 dpi. Homogenates were filtered and used to infect 75 cm
2 flasks
of Vero cells. At 2 dpi, cell culture supernatants were diluted 1:10
in L-15 medium and mixed with equal volumes of defibrinated
sheep blood to prepare a blood meal for the second passage. The
cycle was repeated a total of 3 times. At 10 dpi of third mosquito
passage, heads and legs of individual mosquitoes were processed as
described above.
For CHIKV competition experiments in specific body parts of
A. albopictus, the mosquitoes were exposed to blood meals
containing 1:1 mixes of [SL07-226V-Apa and SL07-226V-
210Q] and [SL07-226V and SL07-226V-210Q-Apa]. Depending
on the experiment, at 1, 2, 3 and 7 dpi whole mosquito bodies,
mosquito carcasses, or mosquito midguts were collected in pools of
ten, and were used for RNA extraction using TRIzol (Invitrogen,
Carlsbad, CA). RNA was RT-PCR amplified, followed by ApaI
restrictase digestion of amplicons as described above. Gel images
were analyzed using TolaLab (version 2.01) and relative fitness for
a given virus during competition was determined as the ratio
between E2-210L and E2-210Q bands in the sample, divided by
the starting ratio of E2-210L and E2-210Q in the blood meal. The
results were expressed as an average value of 2 pools of 10
mosquitoes midguts per pool.
For CHIKV competition experiments in intrathoracically
infected mosquitoes, 5 pfu of SL07-226V-Apa and 5 pfu of
SL07-226V-210Q in 0.5 mL of L-15 media were directly injected
into thoraxes of cold-anesthetized A. albopictus (Galveston colony)
using capillary needles as described previously [69]. RNA from 2
pools, 5 mosquitoes/pool, was extracted at 1 and 2 dpi and
processed as described above.
To investigate the relationship between the blood meal titers
and infection rates in A. albopictus, the SL07-226V and SL07-
226V-210Q viruses individually were serially 10-fold diluted,
mixed with defibrinated sheep blood and presented orally to A.
albopictus (Thailand). At 10 dpi individual mosquitoes were
triturated in one mL of MEM and used to infect 5x10
4 Vero
cells in duplicate in 96 well plates. CHIKV was detected by
observing virus-induced CPE. The difference in the infection rates
between SL07-226V and SL07-226V-210Q was tested for
significance with a two-tailed Fisher `s exact test. The oral infectious
dose 50% (OID50) values were calculated using the PriProbit
program (version 1.63).
For VLP experiments, A. albopictus (Thailand) were infected with
1:1 mixes (based on i.u. titers) of GFP- or CFP-expressing
subgenomic replicons packaged into VLPs using CHIKV helpers
that differed by substitutions at positions E1-226 and E2-210
(Figure 6A and 7A). At 1 and 2 dpi, 5–10 mosquito midguts were
dissected in PBS, and cut longitudinally to generate monolayers of
epithelial cells. These sheets were rinsed in PBS to remove residual
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applied and the midgut sheets were immediately analyzed by
fluorescent microscopy to determine the numbers of cells
expressing GFP and CFP in the same field of vision. One or two
fields of vision were analyzed for each midgut sheet. In parallel
experiment, midguts infected with VLPs packaged using helpers
that differ by substitutions at position E2-210 were dissected at 1, 2
and 3 dpi, collected in pools of ten, which were used for RNA
extraction using TRIzol (Invitrogen). The RNA was processed as
described above.
To demonstrate that replicon and helper RNAs did not
recombine to generate infectious virus capable of autonomous
replication, 30 mosquitoes were infected with VLPs mixes and at
7 dpi were triturated in 1 mL of MEM, filter sterilized and 300 mL
of homogenate was used to infect each of 3 wells of confluent Vero
cells in six-well plates. After 1 h of infection at 37uC, 2 mL of
MEM was added to each well, followed by incubation at 37uC
with 5% CO2. Cells were observed daily for signs of CPE for 5
days.
CHIKV competition in Vero and 293 cells
To investigate the effect of substitutions at E2-210 on CHIKV
fitness in Vero and 293 cells, these cells were infected at a
multiplicity 0.1 pfu/cell in triplicate with 1:1 mixtures of [SL07-
226V-Apa and SL07-226V-210Q] and [SL07-226V and SL07-
226V-210Q-Apa] viruses. Cells were maintained at 37 uC with 5%
CO2 in MEM and at 2 dpi, supernatants were collected for RNA
extraction and processed as described above.
Supporting Information
Figure S1 Evolutionary history of the E1-A226V and E2-
L210Q substitutions in different CHIKV lineages of the
ECSA clade. Black arrows correspond to the emergence and
movement of the CHIKV lineages with the E1-226A residue. Red
arrows correspond to the acquisition of the E1-A226V substitu-
tion. Blue arrow corresponds to acquisition of the E2-L210
substitution. The graph was constructed based on the data
published in [24,27–30].
(TIF)
Figure S2 The effect of the E2-L210Q substitution on
CHIKV fitness in Vero cells. Above each figure is a schematic
representation of the viruses used in the competition assay. Vero
cells were infected at multiplicity of infection of ,0.1 pfu/cell in
triplicate with a 1:1 mixture of [SL07-226V-Apa and SL07-226V-
210Q] (A) and [SL07-226V and SL07-226V-210Q-Apa] (B).A t
2 dpi cell culture supernatants were collected for RNA extraction
and viral RT-PCR analysis. The relative fitness (RF) within a
given competition was determined as the average ratio between
E2-210L and E2-210Q bands in the sample (r), divided by the
starting ratio of E2-210L and E2-210Q bands in the inoculum (i)
used for infection.
(TIF)
Figure S3 The effect of the E2-L210Q substitution on
CHIKV fitness in A. aegypti (Galveston colony). Above is a
schematic representation of the viruses used in the competition
assay. Asterisks indicate authentic (w.t.) residues for the SL07
strain at the indicated positions. Graph shows numbers and
proportions of mosquitoes containing virus populations expressing
leucine (210L), glutamine (210Q) or a mixture of both residues
(210L/210Q) in heads and legs of A. aegypti (Galveston colony)
assayed at 10 dpi. BM indicates combined titers of CHIKV (E2-
210L and E2-210Q) in blood meals used for mosquito infection.
The difference in number of mosquitoes with E2-210L versus E2-
210Q residues was tested for significance with a one-tailed
McNemar test.
(TIF)
Figure S4 Effect of the E2-L210Q substitution on
replication of CHIKV replicon particles in A. albopictus
midguts after oral infection with VLPs. A - schematic
representation of VLP production and the experimental design
used in the mosquito infectivity study. A. albopictus (Thailand
colony) were orally infected with blood meals containing
3x10
6 i.u./mL of GFP/210Q/226V and 3x10
6 i.u./mL of
CFP/210L/226V VLPs. At 1, 2 and 3 dpi, mosquito midguts
were dissected and 2 pools of 5 midguts per pool were used for
RNA extraction and RT-PCR analysis (B). Relative fitness (RF)
was determined as the average ratio between bands correspond-
ing to VLPs expressing E2-210Q and E2-210L residues in the
sample, divided by the initial ratio of E2-210Q and E2-210L
bands in the BM used for mosquito infections.
(TIF)
Figure S5 Effect of the E2-L210Q substitution expressed
in the background of the E1-226A residue on dissemi-
nation of CHIKV in A. albopictus mosquitoes (Thai-
land). Above is a schematic representation of the viruses used in
the competition assay. Asterisks indicate authentic (w.t.) residues
for the SL07 CHIKV strain at the indicated positions. A 1:1
mixture of viruses SL07 and SL07-210Q-Apa was presented
orally to A. albopictus and at 10 dpi, the presence of disseminated
E2-210L and E2-210Q CHIKV infection was assayed as
described in the Materials and Methods. Graphs show numbers
and proportions of mosquitoes containing virus populations
expressing leucine (210L), glutamine (210Q) or containing both
residues (210L/210Q) in mosquito heads and legs (representing
disseminated infections). The difference in numbers of mosqui-
toes with E2-210L versus E2-210Q residues was tested for
significance with a one-tailed McNemar test. BM indicates
combined titers of competitors in blood meal used for mosquito
infection.
(TIF)
Table S1 Recovery of the viruses after electroporation
of in vitro transcribed RNA. a – amino acids at positions E1-
226. b – amino acids at positions E2-210. c – specific infectivity of
in vitro transcribed RNA expressed as pfu/1 mgRNA. d –
supernatants of electroporated Vero cells were collected at 48 h.
Virus titers were determined by titration on Vero cells and
expressed as Log10(pfu)/mL. h – hours post electroporation.
(DOC)
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